# ACURATE Prime XL Human Feasibility Study

> **NCT05224245** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 13 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** ACURATE Prime XL Transfemoral Aortic Valve System

## Key facts

- **NCT ID:** NCT05224245
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-03
- **Primary completion:** 2022-06-16
- **Final completion:** 2023-05-24
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224245, "ACURATE Prime XL Human Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05224245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*